Unicycive Therapeutics, Inc.(UNCY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

UNCY Unicycive Therapeutics, Inc.

Trading 10-13 14:39:03 EDT

3.70

-0.35

-8.77%

High4.02	Low3.67	Vol1.34M
Open3.99	D1 Closing4.05	Amplitude8.64%
Mkt Cap102.93M	Tradable Cap100.60M	Total Shares27.86M
T/O5.09M	T/O Rate4.91%	Tradable Shares27.23M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"UNCY","market":"US","secType":"STK","nameCN":"Unicycive Therapeutics, Inc.","latestPrice":3.695,"timestamp":1791916740890,"preClose":4.05,"halted":0,"volume":1337896,"delay":0,"changeRate":-0.08765432098765433,"floatShares":27225798,"shares":27855300,"eps":-1.558501,"marketStatus":"Trading","change":-0.355,"latestTime":"10-13 14:39:03 EDT","open":3.99,"high":4.02,"low":3.67,"amount":5085043.2748752,"amplitude":0.08642,"askPrice":3.7,"askSize":310,"bidPrice":3.69,"bidSize":5,"shortable":3,"etf":0,"ttmEps":-1.558501,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1791921600000},"marketStatusCode":2,"adr":0,"listingDate":1623988800000,"exchange":"NASDAQ","adjPreClose":4.05,"preHourTrading":{"tag":"盘前","latestPrice":4.02,"preClose":4.05,"latestTime":"08:33 EDT","volume":113,"amount":455.9000255,"timestamp":1791894796575,"change":-0.03,"changeRate":-0.007407,"amplitude":0.007407},"postHourTrading":{"tag":"盘后","latestPrice":4.1111,"preClose":4.05,"latestTime":"19:53 EDT","volume":1232,"amount":5026.1017,"timestamp":1791849218175,"change":0.0611,"changeRate":0.015086,"amplitude":0.012617},"volumeRatio":2.094733,"impliedVol":2.9203,"impliedVolPercentile":0.966},"requestUrl":"/m/hq/s/UNCY/tweets","defaultTab":"tweets","newsList":[{"id":"2672513907","title":"Unicycive Therapeutics Appoints Meredith Manning to Board, Names Her Nominating Committee Chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2672513907","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672513907?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:05","pubTimestamp":1790852739,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics appoints Meredith Manning to board, names her nominating committee chairUnicycive Therapeutics appointed Meredith Manning to its board.Manning joined the audit, compensation, no","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL422pkh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","LU2210149790.SGD","LU0823416689.USD","LU2210150020.SGD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","LU0314104364.USD","SG9999014005.SGD","SG9999014021.USD","BCDF","LU0109394709.USD","LU2324357040.USD","NDAQ","IE00BGHQF748.EUR","SG9999014013.SGD","LU2095319765.USD","BK4112","LU2065170008.USD","BK4585","LU2065171311.SGD","NBIX","BK4139","LU0154245756.USD","IE00BQXX3C00.GBP","BK4588","LU2065169927.USD","IE00BQXX3D17.EUR","SG9999014039.USD","IE00BKPKM429.USD","LU2065171402.SGD","LU0154245673.USD","UNCY","LU0320765992.SGD","IE00B3QW5Z07.USD","LU0889565916.HKD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","IE00BQXX3F31.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672751806","title":"Unicycive Therapeutics Appoints Meredith Manning to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2672751806","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672751806?lang=en_us&edition=fundamental","pubTime":"2026-10-01 19:05","pubTimestamp":1790852700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA36Y3JF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","UNCY","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671245933","title":"Unicycive Therapeutics Price Target Cut to $13.00/Share from $15.00 by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2671245933","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671245933?lang=en_us&edition=fundamental","pubTime":"2026-09-29 23:49","pubTimestamp":1790696940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/UNCY/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671437692","title":"Unicycive Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $13 from $15","url":"https://stock-news.laohu8.com/highlight/detail?id=2671437692","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671437692?lang=en_us&edition=fundamental","pubTime":"2026-09-29 23:26","pubTimestamp":1790695595,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nAZN4TMMN8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","UNCY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216406","title":"Unicycive Therapeutics announces resubmission of NDA for OLC","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216406","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216406?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:15","pubTimestamp":1790680531,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics (UNCY) announced the resubmission of its New Drug Application, NDA, for oxylanthanum carbonate, OLC, the Company’s investiga...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-announces-resubmission-of-nda-for-olc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-announces-resubmission-of-nda-for-olc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","UNCY","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671421639","title":"Unicycive Resubmits FDA NDA for Oxylanthanum Carbonate Phosphate Binder","url":"https://stock-news.laohu8.com/highlight/detail?id=2671421639","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671421639?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679917,"startTime":"0","endTime":"0","summary":"Unicycive resubmits FDA NDA for oxylanthanum carbonate phosphate binderUnicycive resubmitted its FDA NDA for oxylanthanum carbonate to treat hyperphosphatemia in CKD patients on dialysis.Filing includ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL2RqzJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","BK4112","LU2210149790.SGD","IE00BKPKM429.USD","IE00BQXX3D17.EUR","NDAQ","IE00BGHQF748.EUR","LU0314104364.USD","BK4585","LU2210150020.SGD","BK4539","SG9999014021.USD","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","LU2095319765.USD","SG9999014013.SGD","UNCY","SG9999014005.SGD","IE00B64PRP62.GBP","IE00BQXX3C00.GBP","BK4588","SG9999014039.USD","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BK4139","BCDF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671521637","title":"Unicycive Therapeutics - FDA Acceptance of Nda Expected Within 30 Days; New Pdufa Date in 6 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2671521637","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671521637?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216374","title":"Unicycive Therapeutics - Nda Resubmission Includes Cmc Data from New Manufacturing Vendor","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216374?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UNCY","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216370","title":"Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216370","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216370?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671216306","title":"Unicycive Therapeutics - FDA Inspection of Original Manufacturing Vendor Assigned but not Completed as of Sept 29, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671216306","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671216306?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:05","pubTimestamp":1790679900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nTUA84XFVD:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UNCY","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671505532","title":"Unicycive Therapeutics - Lawsuit Alleges Violations Related to Oxylanthanum Carbonate Phosphate Binder Statements - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2671505532","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671505532?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:33","pubTimestamp":1790627597,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0DO:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671250555","title":"Unicycive Therapeutics - Securities Class Action Lawsuit Filed Against Unicycive Therapeutics and Certain Officers on Sept 3, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2671250555","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671250555?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:33","pubTimestamp":1790627597,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0DO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["UNCY","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671505862","title":"Unicycive Therapeutics Faces Securities Class Action Tied to Oxylanthanum Phosphate Binder NDA Statements","url":"https://stock-news.laohu8.com/highlight/detail?id=2671505862","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671505862?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:31","pubTimestamp":1790627516,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics faces securities class action tied to oxylanthanum phosphate binder NDA statementsSecurities class action filed Sept. 3, 2026 in U.S. District Court, Northern District of Califo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDLbWSn24:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UNCY","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669670631","title":"Unicycive Therapeutics (UNCY) Gets a Buy from H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2669670631","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669670631?lang=en_us&edition=fundamental","pubTime":"2026-09-22 01:57","pubTimestamp":1790013421,"startTime":"0","endTime":"0","summary":"In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Unicycive Therapeutics, with a price target of $...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/unicycive-therapeutics-uncy-gets-a-buy-from-h-c-wainwright-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/unicycive-therapeutics-uncy-gets-a-buy-from-h-c-wainwright-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","UNCY","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667866173","title":"Unicycive Therapeutics Faces Securities Lawsuit After 39% Stock Plunge Over Repeat FDA Manufacturing Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2667866173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667866173?lang=en_us&edition=fundamental","pubTime":"2026-09-14 21:44","pubTimestamp":1789393468,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics, Inc. ($UNCY) is facing a federal securities lawsuit after its shares fell sharply following news that the FDA had issued a ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/unicycive-therapeutics-faces-securities-lawsuit-after-39-stock-plunge-over-repeat-fda-manufacturing-setback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/unicycive-therapeutics-faces-securities-lawsuit-after-39-stock-plunge-over-repeat-fda-manufacturing-setback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4539","BK4139","LABU","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666537805","title":"Unicycive Therapeutics Outlines Oxylanthanum Carbonate Program for Hyperphosphatemia in Dialysis Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2666537805","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666537805?lang=en_us&edition=fundamental","pubTime":"2026-09-10 03:03","pubTimestamp":1788980586,"startTime":"0","endTime":"0","summary":"Unicycive Therapeutics outlines oxylanthanum carbonate program for hyperphosphatemia in dialysis patientsUnicycive outlined near-term plans to resubmit the NDA for oxylanthanum carbonate, its lead pro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL55XxTR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664855885","title":"Unicycive Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855885","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664855885?lang=en_us&edition=fundamental","pubTime":"2026-09-01 19:05","pubTimestamp":1788260700,"startTime":"0","endTime":"0","summary":"LOS ALTOS, Calif., Sept.  01, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “C","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/01/3353981/0/en/unicycive-therapeutics-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ODD","IE0009354923.USD","BK4539","BK4183","UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282383","title":"Unicycive Therapeutics price target raised to $15 from $13 at Benchmark","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282383","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282383?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:40","pubTimestamp":1787229649,"startTime":"0","endTime":"0","summary":"Benchmark analyst Bruce Jackson raised the firm’s price target on Unicycive Therapeutics (UNCY) to $15 from $13 and keeps a Speculative Buy rating ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-price-target-raised-to-15-from-13-at-benchmark-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-price-target-raised-to-15-from-13-at-benchmark-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UNCY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660811404","title":"U.S. Research Roundup-Amgen, Analog Devices, Moderna","url":"https://stock-news.laohu8.com/highlight/detail?id=2660811404","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660811404?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:47","pubTimestamp":1787212055,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Amgen, Analog Devices, ModernaAug 20 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amgen, Analog D","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4N44H0HP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","ADI","ARTY","IBBQ","KIDS","IHE","UNCY","MRVL","XNTK","SMHX","KBWP","HCA","RARE","CRWD","SNOW","FRNM","LOW","TGT","NIQ","ALL","TRUH","WOLF","PGR","APA","PCTY","RLAY","GKOS","EPR","TJX","IHF","MRK","ADSK","MSGE","CING","WDAY","BILL","ALIT","SPHR","XLV","EL","AIPI","LNSR","LWAY","WHD","PJP","MRNA","WISE","ABBV","NRGV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660148835","title":"Unicycive Therapeutics price target lowered to $20 from $22 at B. Riley","url":"https://stock-news.laohu8.com/highlight/detail?id=2660148835","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660148835?lang=en_us&edition=fundamental","pubTime":"2026-08-17 15:39","pubTimestamp":1786952395,"startTime":"0","endTime":"0","summary":"B. Riley lowered the firm’s price target on Unicycive Therapeutics (UNCY) to $20 from $22 and keeps a Buy rating on the shares. The Q2 update was c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-price-target-lowered-to-20-from-22-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/unicycive-therapeutics-price-target-lowered-to-20-from-22-at-b-riley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["UNCY"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.unicycive.com","stockEarnings":[{"period":"1week","weight":-0.0334},{"period":"1month","weight":-0.2344},{"period":"3month","weight":-0.2241},{"period":"6month","weight":-0.4189},{"period":"1year","weight":-0.0878},{"period":"ytd","weight":-0.2981}],"compareEarnings":[{"period":"1week","weight":0.0042},{"period":"1month","weight":0.0181},{"period":"3month","weight":0.0349},{"period":"6month","weight":0.1117},{"period":"1year","weight":0.1915},{"period":"ytd","weight":0.141}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Unicycive Therapeutics, Inc., a biotechnology company, develops treatments for various medical conditions in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb (Oxylanthanum Carbonate), which is being developed for the treatment of hyperphosphatemia in patients with chronic kidney disease. Unicycive Therapeutics, Inc. has license agreements with Shilpa Medicare Ltd; Sphaera Pharma Pte. Ltd.; Syneos Health LLC; Inotiv; Lee's Pharmaceutical (HK) Limited; Celerion; and Lotus International Pte Ltd. The company was incorporated in 2016 and is based in Los Altos, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.078139},{"month":2,"riseRate":0.6,"avgChangeRate":0.088088},{"month":3,"riseRate":0.4,"avgChangeRate":0.59683},{"month":4,"riseRate":0.4,"avgChangeRate":-0.11937},{"month":5,"riseRate":0.4,"avgChangeRate":-0.060546},{"month":6,"riseRate":0,"avgChangeRate":-0.217882},{"month":7,"riseRate":0.2,"avgChangeRate":-0.068802},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.095849},{"month":9,"riseRate":0.5,"avgChangeRate":0.016162},{"month":10,"riseRate":0.666667,"avgChangeRate":0.019583},{"month":11,"riseRate":0.6,"avgChangeRate":0.060673},{"month":12,"riseRate":0.4,"avgChangeRate":0.09852}],"exchange":"NASDAQ","name":"Unicycive Therapeutics, Inc.","nameEN":"Unicycive Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Unicycive Therapeutics, Inc.(UNCY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Unicycive Therapeutics, Inc.(UNCY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Unicycive Therapeutics, Inc.,UNCY,Unicycive Therapeutics, Inc.股票,Unicycive Therapeutics, Inc.股票老虎,Unicycive Therapeutics, Inc.股票老虎国际,Unicycive Therapeutics, Inc.行情,Unicycive Therapeutics, Inc.股票行情,Unicycive Therapeutics, Inc.股价,Unicycive Therapeutics, Inc.股市,Unicycive Therapeutics, Inc.股票价格,Unicycive Therapeutics, Inc.股票交易,Unicycive Therapeutics, Inc.股票购买,Unicycive Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Unicycive Therapeutics, Inc.(UNCY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Unicycive Therapeutics, Inc.(UNCY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction